Leaderboard

En | De
No articles selected!     View Cart  
You are here: Dermatology » Skin Neoplasms » Melanoma 14. January 2026
Search
medline.ch
Melanoma
Advanced search
Dermatology
Acne
Alopecia
Dermatitis
Infectious Skin Diseases
Photosensitivity Disorder
Psoriasis
Skin Neoplasms
Melanoma
Others
Skin Ulcer
Urticaria
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 2240  Previews Next
   
   Articles 1 - 20 / 44796  
   
[Primary anal melanoma with visceral dissemination: a case presentation].
Rev Gastroenterol Peru
Huanay-Martínez DA, Bellido-Caparó Á, Garcia-Encinas C, Ventura-León A.
PMID: 41530077 [PubMed - indexed for MEDLINE]


Evolution of the sentinel lymph node procedure following the approval of adjuvant anti-PD-1 therapy for stage IIB and IIC melanoma: A multicenter study from RICMEL database.
Ann Dermatol Venereol
Deriouich M, Levard R, Tagmouti T, Sanogo D, Cassecuel J, Khammari A, Quereux G, Dompmartin A, Dreno B, L'Orphelin JM.
PMID: 41529551 [PubMed - as supplied by publisher]


Evaluation and Enhancement of the Prognostic Ability of the Eighth Edition of TNM Staging in Cutaneous Malignant Melanoma: A Population-Based Study of 111,871 Cases Using Machine Learning.
Br J Dermatol
Mortagy M, Cliff-Patel N, Askary R, Bologan AM, Abdelhameed A, Burns D, Ramage J, Akhras V.
PMID: 41527920 [PubMed - as supplied by publisher]


Prognostic Value of a Novel Nuclear Grading of Cutaneous Melanoma: The UNC Chapel Hill Method.
Am J Surg Pathol
McAlpine SG, Srivatsa S, Jones PC, Davari D, Lei V, Melendez-Gonzalez M, Conlon K, Gebrekidan M, Moschos SJ, Collichio FA, Sorah J, Edmiston SN, Conway K, Miedema J, Ollila DW, Thomas NE, Googe PB.
PMID: 41527214 [PubMed - indexed for MEDLINE]


An extension of the validation cohort of the Dutch Early-Stage Melanoma (D-ESMEL) study for stage-specific analyses.
Eur J Epidemiol
Zhou C, Mooyaart AL, Hulscher N, Kerkour T, Ouwerkerk J, Louwman MWJ, Wakkee M, Li Y, Voorham QJM, Bruggink A, Nijsten TEC, Hollestein LM.
PMID: 41524883 [PubMed - as supplied by publisher]


Letter to the Editor regarding: "Pre-and post-analytical guidelines for the microscopic diagnosis of melanoma: recommendations from the Brazilian Society of Pathology".
An Bras Dermatol
Jabur da Cunha JA, Gomes Tarle R, Tassara Tavares G.
PMID: 41518772 [PubMed - as supplied by publisher]


Impact of a Teledermatology-Based Referral Model on Melanoma Diagnostic Pathways and Clinicopathologic Features: A Retrospective Comparative Study Between Face-to-Face Consultation (2019) and Teledermatology (2022) in a Tertiary Hospital.
J Clin Med
Cebolla-Verdugo M, Husein El-Ahmed H, Ramos-Pleguezuelos FM, Ruiz-Villaverde R.
PMID: 41517516 [PubMed]


ChronoimmunoTOX: A Single-Institution Retrospective Study on How the Time of Administration Impacts Immune Checkpoint Inhibitor Efficacy and Toxicity in Melanoma.
J Clin Med
Nepote A, Burghgraeve G, Pedrani M, Gomez Ramos AJ, Saporita I, Spataro V, Espeli V, Pereira Mestre R, Sangiolo D, Imbimbo M, Mangas C.
PMID: 41517320 [PubMed]


Utility of High-Frequency Ultrasound in Preoperative Evaluation of the Thickness of Cutaneous Melanoma.
Diagnostics (Basel)
Zhao Y, Yang F, Li D, Wang Q, Guo L, Ren W, Shan D, Qin C.
PMID: 41515666 [PubMed]


MicroRNAs as Diagnostic and Prognostic Biomarkers in Melanoma and Non-Melanoma Skin Cancers: An Updated Review.
Diagnostics (Basel)
Oiegar A, Tigu AB, Baican A, Candrea E, Negrutiu M, Danescu S.
PMID: 41515546 [PubMed]


Investigating Chronic Toxicity, Diet, Patient-Reported Outcomes and the Microbiome in Immunotherapy-Treated Metastatic Melanoma Survivors: A New Frontier.
Nutrients
Robert M, Saha S, Dizman N, Rohlfs M, Sirmans E, Simon J, Amaria RN, Glitza Oliva IC, Tawbi HA, Davies MA, Ikeguchi A, Basen-Engquist K, Schadler K, Roth ME, Song W, Zhang X, Ajami NJ, Cohen L, Wargo JA, Peterson CB, McQuade JL, Daniel CR.
PMID: 41515159 [PubMed - indexed for MEDLINE]


Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus.
Cancers (Basel)
Alban J, Bowen RC, Reichstein DA, McKean M, Lutzky J, Weis E, Carvajal RD, Dulka S, Morse BG, Butler MO, Rapisuwon S, Kim KB, Chandrasekaran S, Warner AB, Zager JS, Chmielowski B, Patel SP, Hernandez-Aya LF, Correa ZM, Fecher LA, Najjar YG, Montazeri K, Shoushtari AN, Javed A, Gombos DS, Salama AKS, Tsai K, Miller FH, Khushalani N, Seedor RS, Lipson EJ, Reddy SA, Buchbinder E, Bhatia S, Pavlick A, Mehmi I, Aaberg T, Ikeguchi AP, Kim IK, Walter SD, Singh AD, Sullivan RJ, Choi JS, Williams BK Jr, Orloff M, Mruthyunjaya P, Schollenberger MD, Gandhi N, Harbour JW, Chandra S.
PMID: 41514630 [PubMed]


Medical support platform for melanoma analysis and detection based on federated learning.
Sci Rep
Laso S, Herrera JL, Flores-Martin D.
PMID: 41513722 [PubMed - as supplied by publisher]


Advances in melanoma immunotherapy: harnessing vaccination as a potential novel immunotherapeutic strategy.
Biochem Pharmacol
Abuelainain DS, Abdel-Aziz AK, Saadeldin MK.
PMID: 41513106 [PubMed - as supplied by publisher]


Diagnostic accuracy of reflectance confocal microscopy for acral lentiginous melanoma.
JAAD Case Rep
Milovanovic U, Pan A, Laborada J, Lam L, Ottuso P, Ravichandran S, Correa-Selm L.
PMID: 41509666 [PubMed]


Risk Factors for Melanoma Survival: DGCR8 as a Predictive Factor for Mortality in Young Patients.
Acta Derm Venereol
Schafer F, Bellolio E, Sepúlveda T, Espinoza M, Orellana JJ, Villaseca MA, Miranda R.
PMID: 41508836 [PubMed - indexed for MEDLINE]


Real-world evaluation of the use of melanoma risk prediction tools by clinicians in Australia: a mixed methods study.
Br J Dermatol
Reyes-Marcelino G, Salam RA, Espinoza D, Watts CG, Steinberg J, Kang YJ, Martin LK, Guitera P, Lo SN, Varey AHR, Scolyer RA, Long GV, Smit AK, Cust AE.
PMID: 41507070 [PubMed - as supplied by publisher]


Targeting the microbiota-miRNA-protease axis: A new therapeutic avenue in melanoma.
FEBS J
Katsoulieris EN, Ioannou P, Afratis NA.
PMID: 41506657 [PubMed - as supplied by publisher]


Phase II trial of interleukin-12 followed by interferon alfa-2b in patients with metastatic malignant melanoma: Results from CALGB 500001 (Alliance).
Cancer Immunol Res
Liu A, Johnson C, Niedzwiecki D, Relation T, Yarlagadda S, Gajewski TF, Carson WE.
PMID: 41505731 [PubMed - as supplied by publisher]


Association between GRIm score and response to nivolumab monotherapy in patients with advanced malignant melanoma.
J Cancer Res Clin Oncol
Oksuz S, Kinikoglu O, Ozkerim U, Isik D, Surmeli H, Ay S, Gundogdu UD, Basoglu T, Odabas H, Turan N.
PMID: 41504775 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 44796    Page 1 of 2240  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1